Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories
November 01 2018 - 11:00AM
Business Wire
Cary 3500 UV-Vis system can run multiple experiments
simultaneously, boosting laboratory efficiency
Agilent Technologies Inc. (NYSE: A) today introduced the Cary
3500 UV-Vis system, an innovative spectrophotometer designed to
help life science, pharma and biopharma research communities
simplify their analyses, optimize laboratory productivity, and
ultimately help bring new therapeutics to market faster. Agilent
will showcase the Cary 3500 UV-Vis system at analytica China, being
held October 31 – November 2, 2018, in Shanghai, China.
Global growth in the development of biological drugs is leading
to the evolution of many new biological entities (NBEs). Before
these NBEs are adapted into therapeutics, laboratories must
accurately characterize each new product and continuously monitor
the quality of these products throughout the development
process.
“The Agilent Cary 3500 provides a critical tool that allows
laboratories to do this more quickly and accurately than is
currently possible,” said Phil Binns, vice president, and general
manager of Agilent's Spectroscopy division. “Our spectroscopy unit
drew upon 70 years of insight and customer collaborations to create
a faster, more robust system—with a lower cost of ownership.”
He noted that the Cary 3500 represents the first significant
advancement in UV-Vis architecture in decades.
The new system enables laboratories to make substantial gains in
efficiency as it can run multiple experiments simultaneously,
allowing labs to obtain more results in the same amount of time—and
it also extends the opportunity to design experiments in ways that
have not been possible before.
The Cary 3500 harnesses the power of a state-of-the-art software
platform and a fast and powerful Xenon flash lamp that is
redefining UV-Vis spectrophotometry. Indeed, the system’s rapid,
accurate, temperature control permits temperature experiments at
ramp rates previously thought to be unattainable, providing more
reliable and robust measurements.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.47 billion in fiscal 2017 and employs 14,500 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on Linked In, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181101005628/en/
Agilent TechnologiesVictoria Wadsworth-Hansen, +1
408-553-2005+45 2933 6980victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024